[Pubmed] Construction of patient trajectories to model clinical trial outcomes: application to myasthenia gravis
Posté : 08 mai 2026 12:00
Front Digit Health. 2026 Apr 22;8:1755031. doi: 10.3389/fdgth.2026.1755031. eCollection 2026.
ABSTRACT
INTRODUCTION: Accurate prediction of patient outcomes in clinical trials is crucial for the timely assessment of treatment efficacy. This study proposes a novel approach to predict patient response using longitudinal clinical data.
METHODS: We construct temporal trajectories from longitudinal data and extrapolate these trajectories to forecast individual patient outcomes. Additionally, we assess when new patients align with established response patterns. The approach is evaluated using data from the MGTX trial involving patients with myasthenia gravis.
RESULTS: Our analysis demonstrates the predictability of patient trajectories and enables automatic clustering of patients based on treatment success. The clustering reveals potential associations with age and smoking status.
DISCUSSION: These findings highlight the potential of trajectory-based methods for early prediction of treatment response in clinical trials. We also discuss possible confounding factors that may influence the observed associations and predictive performance.
PMID:42099932 | PMC:PMC13143922 | DOI:10.3389/fdgth.2026.1755031
Source: https://pubmed.ncbi.nlm.nih.gov/4209993 ... 1&v=2.20.0